1. Home
  2. GNLX
  3. GNLX News

Latest Genelux Corporation (GNLX) News on November 25, 2024

Genelux doses first subject in Phase II trial of NSCLC treatment

Clinical Trials Arena

a month ago

Genelux doses first subject in Phase II trial of NSCLC treatment

MT Newswires

6 months ago

Top Midday Decliners

MT Newswires

6 months ago

Top Premarket Gainers

Thomson Reuters StreetEvents

10 months ago

Q4 2023 Washington Trust Bancorp Inc Earnings Call

Share on Social Networks: